Joint Webinar presented by: Livingston Securities and Fish & Richardson

Thursday, February 9, 2012
1:00 PM - 2:30 PM ET

Webinar Outline:

• An overview of biotech IPO in 2011
• Deals and exits in therapeutics, diagnostics and medical device
• IPO performance and pipeline
• What is on the horizon?
• Updates in Patent Law Reform – The America Invents Act
• Impact of new patent law on target company portfolios
• Preview of what's to come in challenging patents and patent portfolios
• Q&A

Speakers:
Mostafa Analoui - Head of Healthcare and Life Science Investment, Livingston Securities
Sean Grygiel, JD - Principal, Fish & Richardson P.C.

Final Presentation

Audio Archive

© Copyright 2012 Fish & Richardson P.C. These materials may be considered advertising for legal services under the laws and rules of professional conduct of the jurisdictions in which we practice. The material contained in this newsletter has been gathered by the lawyers at Fish & Richardson P.C. for informational purposes only and is not intended to be legal advice. Transmission is not intended to create and receipt does not establish an attorney-client relationship. Legal advice of any nature should be sought from legal counsel. For more information about Fish & Richardson P.C. and our practices, please visit www.fr.com.